BioCentury
ARTICLE | Financial News

TesoRx raises $10 million in series B-1

August 6, 2014 12:59 AM UTC

TesoRx Pharma LLC (Menlo Park, Calif.) raised $10 million in a series B-1 round from undisclosed existing and new investors. TesoRx's TSX-002 is slated to begin Phase III testing in 1Q15 to treat hypogonadism. TSX-002 is an oral pro-liposomal formulation of unmodified testosterone. ...